Irish Meningitis and Sepsis Reference Laboratory, Children's Health Ireland at Temple Street, Dublin, Ireland.
Clinical Innovation Unit and Department of Clinical Microbiology Rotunda Hospital Dublin, Dublin, Ireland.
Eur J Clin Microbiol Infect Dis. 2020 Dec;39(12):2335-2344. doi: 10.1007/s10096-020-03971-z. Epub 2020 Jul 14.
The purpose of this study was to investigate H. influenzae epidemiology in the Republic of Ireland. We performed serotyping, multi-locus sequence typing (MLST) and susceptibility testing on H. influenzae isolates received by the Irish Meningitis and Sepsis Reference Laboratory from 2010 to 2018. Three hundred sixty-seven invasive and 41 non-invasive infection (NII) isolates were received. Invasive isolates were mostly recovered from paediatric (21%) and elderly (42%) populations. Invasive disease was more prevalent in females of childbearing age (72%) compared with males the same age (28%). Non-typeable H. influenzae (NTHi) predominated among invasive (83%) and NII (95%). Invasive Hib disease isolates were infrequent (4%, n = 15). Among invasive disease, Hif was the commonest encapsulated serotype (10%, n = 37), and the only encapsulated serotype detected in NII (5%, 2/41). The first PCR-confirmed serotypes d and a in Ireland were characterised among invasive disease in 2017 and 2018, respectively. MLST revealed a diverse NTHi population, while encapsulated serotypes were clonal. Sequence type (ST) 103 (n = 14) occurred exclusively in invasive NTHi disease. Ampicillin resistance (AmpR) was 18% among invasive isolates and 22% in NII. β-Lactamase production was the main source of ampicillin resistance in invasive and NII isolates. We detected β-lactamase negative ampicillin resistance (BLNAR) among invasive isolates. We report an NTHi fluoroquinolone-resistant clone: ST1524 among invasive (n = 2) and NII isolates (n = 2). The Hib vaccine has positively impacted on Hib disease in Ireland, given the low frequency of Hib. The dominance of NTHi, emergence of serotypes a and d and BLNAR suggest a changing H. influenzae epidemiology in Ireland.
这项研究的目的是调查爱尔兰的流感嗜血杆菌流行病学。我们对爱尔兰脑膜炎和败血症参考实验室从 2010 年至 2018 年收到的流感嗜血杆菌分离株进行了血清分型、多位点序列分型(MLST)和药敏试验。共收到 367 例侵袭性和 41 例非侵袭性感染(NII)分离株。侵袭性分离株主要来自儿科(21%)和老年人群(42%)。侵袭性疾病在育龄女性(72%)中比同年龄男性(28%)更为普遍。非定型流感嗜血杆菌(NTHi)在侵袭性(83%)和 NII(95%)中占主导地位。侵袭性 Hib 疾病分离株很少见(4%,n=15)。在侵袭性疾病中,Hif 是最常见的有荚膜血清型(10%,n=37),也是 NII 中唯一检测到的有荚膜血清型(5%,2/41)。2017 年和 2018 年,爱尔兰首次通过 PCR 确认的血清型 d 和 a 分别在侵袭性疾病中得到了描述。MLST 显示了一个多样化的 NTHi 群体,而有荚膜血清型是克隆的。ST103(n=14)仅存在于侵袭性 NTHi 疾病中。侵袭性分离株的氨苄西林耐药率(AmpR)为 18%,NII 为 22%。β-内酰胺酶的产生是侵袭性和 NII 分离株氨苄西林耐药的主要来源。我们在侵袭性分离株中检测到β-内酰胺酶阴性氨苄西林耐药(BLNAR)。我们报告了一种氟喹诺酮耐药的 NTHi 克隆:ST1524,存在于侵袭性(n=2)和 NII 分离株(n=2)中。由于 Hib 的频率较低,Hib 疫苗对爱尔兰的 Hib 疾病产生了积极影响。NTHi 的主导地位、血清型 a 和 d 的出现以及 BLNAR 表明爱尔兰的流感嗜血杆菌流行病学正在发生变化。